Loss of the p53 transactivation domain results in high amyloid aggregation of the Δ40p53 isoform in endometrial carcinoma cells
Nataly Melo dos Santos(Universidade Federal Fluminense), Etel Rodrigues Pereira Gimba(Universidade Federal Fluminense), Murilo Ramos Rocha(Instituto Nacional de Câncer - INCA), José Andrés Morgado‐Díaz(Cellular Research (United States)), Luciana P. Rangel(Universidade Federal do Rio de Janeiro), Giulia D. S. Ferretti(Medical University of South Carolina), Guilherme A. P. de Oliveira(Universidade Federal do Rio de Janeiro), Jerson L. Silva(D’Or Institute for Research and Education), Murilo M. Pedrote(Universidade Federal do Rio de Janeiro)
Cited by 50
Related Papers
PCA3 noncoding RNA is involved in the control of prostate-cancer cell survival and modulates androgen receptor signaling
|BMC Cancer|2012|155
Ligand Binding and Hydration in Protein Misfolding: Insights from Studies of Prion and p53 Tumor Suppressor Proteins
|Accounts of Chemical Research|2009|110
Phase separation of p53 precedes aggregation and is affected by oncogenic mutations and ligands
|Chemical Science|2021|108
p53 reactivation with induction of massive apoptosis-1 (PRIMA-1) inhibits amyloid aggregation of mutant p53 in cancer cells
|Journal of Biological Chemistry|2019|86